Perrigo

Perrigo

Quality, affordable self-care products trusted by consumers globally. Learn more

Launch date
Employees
Market cap
AUD5.7b
Enterprise valuation
AUD11.2b (Public information from Sep 2024)
Allegan Michigan (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues5.1b4.1b4.5b4.7b4.5b4.7b4.9b
% growth5 %(18 %)8 %5 %(4 %)5 %3 %
EBITDA1.3b886m511m654m693m787m838m
% EBITDA margin26 %21 %11 %14 %15 %17 %17 %
Profit(163m)(68.9m)(141m)(12.7m)(166m)92.7m184m
% profit margin(3 %)(2 %)(3 %)-(4 %)2 %4 %
EV / revenue1.8x1.7x1.8x1.6x1.6x1.5x1.4x
EV / EBITDA6.8x7.7x15.8x11.8x10.5x9.0x8.2x
R&D budget178m122m123m123m---
R&D % of revenue4 %3 %3 %3 %---

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO

N/A

-

$600m

Post IPO Equity
*
N/A

N/A

Post IPO Debt
Total Funding-

Recent News about Perrigo

Edit
More about Perrigoinfo icon
Edit

Perrigo Company plc is a leading global provider of high-quality, affordable self-care products. Operating in the consumer healthcare market, Perrigo serves a diverse range of clients including retail chains, pharmacies, and direct consumers. The company’s business model focuses on manufacturing and distributing over-the-counter (OTC) healthcare products, infant formulas, and nutritional products. Perrigo generates revenue through the sale of these products under both its own brand and private labels for retailers. The company leverages its extensive manufacturing capabilities and commitment to quality to maintain competitive pricing while ensuring product efficacy and safety. Additionally, Perrigo is dedicated to community well-being through its charitable foundation, which supports educational programs, healthcare access, and disaster relief efforts.

Keywords: self-care, OTC healthcare, infant formulas, nutritional products, private labels, retail chains, pharmacies, manufacturing, quality, community well-being.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Perrigo

Edit
HRA Pharma
ACQUISITION by Perrigo Sep 2021
Velcera
ACQUISITION by Perrigo Feb 2013
Fera Pharmaceuticals
ACQUISITION by Perrigo Jun 2013
Omega Pharma NV
ACQUISITION by Perrigo Mar 2015
ScarAway
ACQUISITION by Perrigo Sep 2015
Geiss, Destin & Dunn
ACQUISITION by Perrigo Aug 2016
Elan Corporation
ACQUISITION by Perrigo Dec 2012
Rosemont Pharmaceuticals
ACQUISITION by Perrigo Mar 2013